Last reviewed · How we verify

NCT04552145: PTvsSD

Physical Therapy vs Surgical Decompression for Lumbar Spinal Stenosis

Recruiting now NA Last updated 22 June 2025
What this trial tests

NA trial testing surgery in Spinal Stenosis in 232 participants. Currently enrolling.

Timeline
1 September 2020
Primary endpoint
30 August 2026
31 August 2027

Quick facts

Lead sponsorNorwegian University of Science and Technology
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment232
Start date1 September 2020
Primary completion30 August 2026
Estimated completion31 August 2027
Sites3 locations across Norway

Drugs / interventions tested

Conditions studied

Sponsor

Norwegian University of Science and Technology

Who can join

Adults 50 to 80, any sex, with Spinal Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized controlled multicenter trail comparing physical therapy to surgical decompression in patients with lumbar spinal stenosis. The 0-hypothesis is that there is no difference in the efficacy of structured physical therapy compared to surgical decompression. Our aim is to evaluate if physical therapy can serve as a nonsurgical alternative for patients with LSS, where the severity of symptoms indicates the need of surgical decompression.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of surgery

Trials testing the same drug.

Other recruiting trials for Spinal Stenosis

Currently open trials in the same condition.

Other Norwegian University of Science and Technology trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04552145.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing